{"id":8552,"date":"2025-11-21T23:02:32","date_gmt":"2025-11-21T23:02:32","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/11\/21\/biotech-news-recursion-moves-through-financial-challenges\/"},"modified":"2025-11-21T23:02:32","modified_gmt":"2025-11-21T23:02:32","slug":"biotech-news-recursion-moves-through-financial-challenges","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/11\/21\/biotech-news-recursion-moves-through-financial-challenges\/","title":{"rendered":"STAT+: Recursion seeks to deliver results, and a VC sees a wave of M&amp;A coming"},"content":{"rendered":"\n<div>STAT+: Recursion seeks to deliver results, and a VC sees a wave of M&#038;A coming<\/div>\n<p> \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Good morning. We\u2019ve got some spicy comments from Mark Cuban, and a pair of biotech Q&amp;As. Let\u2019s get to it.<\/p>\n<h2 class=\"wp-block-heading\" id=\"h-how-mark-cuban-nbsp-plans-to-f-up-nbsp-health-care\">How Mark Cuban\u00a0plans to \u2018f\u2014 up\u2019\u00a0health care<\/h2>\n<p>This week, my colleagues and I scheduled 30 minutes to talk with Mark Cuban for \u201cThe Readout LOUD\u201d podcast. The conversation ended up lasting almost an hour. Cuban did not want to stop talking to us about drug pricing.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/11\/21\/biotech-news-recursion-moves-through-financial-challenges\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/11\/21\/biotech-news-recursion-moves-through-financial-challenges\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: Recursion seeks to deliver results, and a VC sees a wave of M&#038;A coming Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Good morning. We\u2019ve got some spicy comments from Mark Cuban, and a pair of biotech Q&amp;As. Let\u2019s get to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-8552","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8552"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=8552"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8552\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=8552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=8552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=8552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}